Growth Metrics

Eli Lilly (LLY) Current Assets (2016 - 2025)

Historic Current Assets for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $55.6 billion.

  • Eli Lilly's Current Assets rose 6991.14% to $55.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $55.6 billion, marking a year-over-year increase of 6991.14%. This contributed to the annual value of $55.6 billion for FY2025, which is 6991.14% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Current Assets is $55.6 billion, which was up 6991.14% from $62.1 billion recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Current Assets peaked at $62.1 billion during Q3 2025, and registered a low of $16.6 billion during Q1 2021.
  • Moreover, its 5-year median value for Current Assets was $22.2 billion (2023), whereas its average is $28.0 billion.
  • In the last 5 years, Eli Lilly's Current Assets plummeted by 226.47% in 2022 and then surged by 9758.43% in 2025.
  • Eli Lilly's Current Assets (Quarter) stood at $18.5 billion in 2021, then dropped by 2.26% to $18.0 billion in 2022, then soared by 42.65% to $25.7 billion in 2023, then rose by 27.26% to $32.7 billion in 2024, then skyrocketed by 69.91% to $55.6 billion in 2025.
  • Its Current Assets stands at $55.6 billion for Q4 2025, versus $62.1 billion for Q3 2025 and $49.9 billion for Q2 2025.